← Back to Search

Procedure

Distal Pharyngeal Airway for Oxygenation During Procedures

N/A
Recruiting
Led By Fouad G Souki, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients scheduled to undergo an elective TEE procedure.
Age > or = 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during procedure (up to 60 minutes)
Awards & highlights

Study Summary

This trial is testing a new device to help deliver oxygen more effectively than a normal nasal tube.

Who is the study for?
This trial is for adults aged 18 or older who are scheduled for an elective Transesophageal Echocardiography (TEE) procedure and can give informed consent. It's not suitable for those with uncontrolled acid reflux or anatomical airway blockages, or any condition that might interfere with the study.Check my eligibility
What is being tested?
The study is testing if the McMurray Enhanced Airway (MEA), a special flexible airway device, provides better oxygenation during TEE than the standard nasal cannula, which is a tube placed in the nostrils.See study design
What are the potential side effects?
Potential side effects may include discomfort from using MEA, possible sore throat after use, and rare risks associated with airway manipulation such as minor bleeding or injury.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for a TEE (heart ultrasound) procedure.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during procedure (up to 60 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and during procedure (up to 60 minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of hypoxia
Secondary outcome measures
Incidence of severe Hypoxia
Incidence of subclinical hypoxia

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Distal Pharyngeal AirwayExperimental Treatment1 Intervention
Participants in this group will use the McMurray enhanced airway to have oxygen delivered throughout a TEE procedure for up to 60 minutes.
Group II: Nasal cannula groupActive Control1 Intervention
Participant in this group will receive oxygen through a nasal cannula during the TEE procedure for up to 60 minutes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
McMurray Enhanced Airway
2019
N/A
~90

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
902 Previous Clinical Trials
410,026 Total Patients Enrolled
Fouad G Souki, MDPrincipal InvestigatorUniversity of Miami

Media Library

McMurray Enhanced Airway (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05974488 — N/A
Airway Blockage Research Study Groups: Distal Pharyngeal Airway, Nasal cannula group
Airway Blockage Clinical Trial 2023: McMurray Enhanced Airway Highlights & Side Effects. Trial Name: NCT05974488 — N/A
McMurray Enhanced Airway (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05974488 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts underway for this trial?

"Contrary to what clinicaltrials.gov indicates, this medical experiment is not presently accepting participants. The trial was first published in October 1st 2023 and last revised on July 26th of the same year; yet 16 other trials are currently open for enrolment at this moment."

Answered by AI
~25 spots leftby Oct 2024